InvestorsHub Logo
Followers 85
Posts 44271
Boards Moderated 1
Alias Born 01/05/2010

Re: None

Monday, 07/04/2011 11:35:33 PM

Monday, July 04, 2011 11:35:33 PM

Post# of 92772

Pfizer’s quit smoking drug raises heart risks by 72 percent:study



http://www.rawstory.com/rs/2011/07/04/pfizers-quit-smoking-drug-raises-heart-risks-by-72-percent-study/


Investors had high hopes for Chantix when Pfizer first launched it in 2006, but reports of suicidal thoughts and other mental health problems in users led Food and Drug Administration (FDA) officials to order a "black box" warning on the drug's label in 2009.

Chantix, which reduces both the craving for and pleasurable effects of cigarettes, is used by heavy smokers who find it difficult to quit. It is one of the biggest-selling stop-smoking drugs in the United States, and has more than 70,000 prescriptions every month in Britain.

Annual sales of around $800 million make Chantix a moderate-sized product for Pfizer, the world's biggest drug maker